Skip to content
-
EVERSANA and UpScriptHealth Announce Integrated, Direct-to-Patient Platform
Apr 14, 2022
EVERSANA and UpScriptHealth Announce Integrated, Direct-to-Patient Platform, Transforming the Patient Journey to Accelerate Therapy Access, Affordability... read more
-
Spotlight Corporate Member of the Month: April 2022
Apr 11, 2022
Week 2 (April 11): ParcelShield Meet ParcelShield, the second of our four corporate members featured in... read more
-
Spotlight Corporate Member of the Month: April 2022
Apr 04, 2022
Week 1 (April 4): Eversana EVERSANA™ is the first of our four corporate members to be... read more
-
EVERSANA unveils global price and market access solution NAVLIN by EVERSANA
Mar 23, 2022
Next generation price and market access platform combining data, software and insights into single ecosystem CHICAGO... read more
-
EVERSANA’s Data & Analytics Platform ACTICS by EVERSANA Named a 2022 Artificial Intelligence Award Winner
Mar 22, 2022
CHICAGO – March 22, 2022 – EVERSANA™, the pioneer of next-generation commercial services to the global... read more
-
ParcelShield Named a 2022 Best Places to Work
Mar 17, 2022
ORLANDO, Fla., March 17, 2022— ParcelShield Holdings, LLC (“ParcelShield”) — the leading provider of technology-enabled predictive... read more
-
The Value of Embedded Specialty Pharmacists Podcast Episode
Feb 16, 2022
Listen to the latest NASP Podcast “The Value of Embedded Specialty Pharmacists.” Sheila Arquette, President &... read more
-
Evoke Pharma and EVERSANA Extend Commercialization Partnership to Further Support GIMOTI
Feb 03, 2022
SOLANA BEACH, CA and CHICAGO,IL – Feb 2, 2022 — Evoke Pharma, Inc. (NASDAQ: EVOK), a... read more
-
Crawford Thomas Recruiting is Your Hiring Resolution for 2022
Jan 18, 2022
Get Candidates Now Connect With Our Team Get Candidates Now ... read more
-
OWP Pharmaceuticals and EVERSANA Announce Partnership to Commercialize Oral Liquid Formulations to Treat Neuroscience Disorders
Jan 05, 2022
CHICAGO — January 5, 2022 — OWP Pharmaceuticals, Inc. is a privately held, neuroscience specialty pharmaceutical... read more